Parallel interleukin 5 synthesis by eosinophils in duodenal and skin lesions of a patient with dermatitis herpetiformis.
Open Access
- 1 July 1995
- Vol. 37 (1) , 132-135
- https://doi.org/10.1136/gut.37.1.132
Abstract
A 59 year old man is presented with a diagnosis of dermatitis herpetiformis. Duodenal and skin biopsy specimens from blisters of both recent and late onset were collected before treatment. Electron microscopy, immunohistochemistry, and in situ hybridisation were performed to analyse the presence of activated eosinophils and the local synthesis of interleukin 5 (IL5). Parallel state of eosinophil activation and IL5 synthesis was found in the duodenal mucosa with total flat mucosa and in skin vesicles of recent onset. It is suggested that duodenal and cutaneous eosinophils can synthesise IL5 and then participate in small bowel and skin lesions.Keywords
This publication has 22 references indexed in Scilit:
- The role of cytokines in the generation of skin lesions in dermatitis herpetiformisBritish Journal of Dermatology, 1993
- Evidence that gluten sensitivity is an immunologic diseaseCurrent Opinion in Gastroenterology, 1993
- Definition of immunoglobulin A receptors on eosinophils and their enhanced expression in allergic individuals.Journal of Clinical Investigation, 1993
- Activated eosinophils in adult coeliac disease: evidence for a local release of major basic protein.Gut, 1992
- Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease.The Journal of Experimental Medicine, 1992
- Lymphocyte Migration into the Skin: The Role of Lymphocyte Homing Receptor (CD44) and Endothelial Cell Antigen (HECA-452)Journal of Investigative Dermatology, 1990
- Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor.The Journal of Experimental Medicine, 1988
- Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors.The Journal of Experimental Medicine, 1988
- Recombinant human interleukin 5 is a selective activator of human eosinophil function.The Journal of Experimental Medicine, 1988
- Histology of linear IgA disease, dermatitis herpetiformis, and bullous pemphigoidThe American Journal of Dermatopathology, 1983